Crossmark Global Holdings Inc. Has $258,000 Stake in Innospec Inc. (NASDAQ:IOSP)

Crossmark Global Holdings Inc. grew its stake in shares of Innospec Inc. (NASDAQ:IOSP) by 23.7% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 2,286 shares of the specialty chemicals company’s stock after buying an additional 438 shares during the period. Crossmark Global Holdings Inc.’s holdings in Innospec were worth $258,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors also recently modified their holdings of IOSP. Vanguard Group Inc. raised its stake in Innospec by 5.5% during the 1st quarter. Vanguard Group Inc. now owns 3,115,167 shares of the specialty chemicals company’s stock worth $401,670,000 after buying an additional 161,249 shares during the period. Allspring Global Investments Holdings LLC lifted its holdings in shares of Innospec by 4.6% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 2,405,770 shares of the specialty chemicals company’s stock valued at $272,069,000 after purchasing an additional 105,311 shares in the last quarter. Assenagon Asset Management S.A. lifted its holdings in shares of Innospec by 98.4% during the 2nd quarter. Assenagon Asset Management S.A. now owns 120,082 shares of the specialty chemicals company’s stock valued at $14,841,000 after purchasing an additional 59,554 shares in the last quarter. Gendell Jeffrey L acquired a new position in shares of Innospec in the 1st quarter valued at approximately $7,090,000. Finally, Cubist Systematic Strategies LLC increased its stake in Innospec by 117.3% during the 2nd quarter. Cubist Systematic Strategies LLC now owns 81,311 shares of the specialty chemicals company’s stock worth $10,049,000 after purchasing an additional 43,898 shares in the last quarter. 96.64% of the stock is currently owned by institutional investors and hedge funds.

Innospec Trading Down 1.3 %

NASDAQ:IOSP opened at $116.68 on Tuesday. The stock has a market capitalization of $2.91 billion, a PE ratio of 20.36 and a beta of 1.08. Innospec Inc. has a 1-year low of $103.97 and a 1-year high of $133.71. The firm has a fifty day simple moving average of $112.76 and a 200 day simple moving average of $118.82.

Innospec (NASDAQ:IOSP) last posted its quarterly earnings results on Tuesday, November 5th. The specialty chemicals company reported $1.35 EPS for the quarter, hitting analysts’ consensus estimates of $1.35. The business had revenue of $443.40 million during the quarter, compared to analysts’ expectations of $442.13 million. Innospec had a return on equity of 13.33% and a net margin of 7.68%. Innospec’s quarterly revenue was down 4.5% on a year-over-year basis. During the same quarter last year, the company posted $1.59 earnings per share. On average, equities analysts predict that Innospec Inc. will post 5.88 earnings per share for the current fiscal year.

Innospec Increases Dividend

The business also recently declared a Semi-Annual dividend, which will be paid on Tuesday, November 26th. Shareholders of record on Monday, November 18th will be issued a $0.79 dividend. This is a boost from Innospec’s previous Semi-Annual dividend of $0.72. This represents a yield of 1.3%. The ex-dividend date of this dividend is Monday, November 18th. Innospec’s dividend payout ratio is currently 26.53%.

Insiders Place Their Bets

In other Innospec news, CFO Ian Cleminson sold 6,602 shares of the business’s stock in a transaction dated Friday, August 23rd. The shares were sold at an average price of $113.60, for a total value of $749,987.20. Following the completion of the sale, the chief financial officer now owns 16,394 shares of the company’s stock, valued at $1,862,358.40. The trade was a 28.71 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Milton C. Blackmore sold 1,035 shares of the firm’s stock in a transaction that occurred on Wednesday, November 13th. The stock was sold at an average price of $122.92, for a total transaction of $127,222.20. Following the transaction, the director now directly owns 9,028 shares in the company, valued at $1,109,721.76. This represents a 10.29 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 11,035 shares of company stock worth $1,267,096 over the last three months. Insiders own 1.52% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, StockNews.com downgraded Innospec from a “strong-buy” rating to a “buy” rating in a research note on Thursday, August 8th.

Innospec Company Profile

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.